Drug Design Reviews - Online

Preface
pp. i-i(1)
Authors: Honan M.; Atta-Ur-Rahman

Novel Approaches for Modulating dUTPase and Uracil-DNA Glycosylase: Potential Uses for Cancer and Viral Chemotherapy
pp. 1-13(13)
Authors: Studebaker A.W.; Ariza M.E.; Balendiran G.K.; Williams M.V.

Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria
pp. 15-28(14)
Authors: Weissig V.; Boddapati S.V.; D'Souza G.G.M.; Cheng S.M.

Cytoprotective Strategy Against Pulmonary Fibrosis
pp. 29-35(7)
Authors: Kuwano K.; Hagimoto N.; Yoshimi M.; Maeyama T.; Nakanishi Y.

Presentation of Neuroendocrine Self in the Thymus: Toward a Novel Type of Vaccine / Immunotherapy
pp. 37-42(6)
Authors: Geenen V.; Brilot F.; Hansenne I.; Louis C.; Martens H.

Nicotinamide and its Pharmacological Properties for Clinical Therapy
pp. 43-52(10)
Authors: Yang J.; Adams J.D.

The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
pp. 53-74(22)
Author: Englebienne P.

Metal-Protein Attenuating Compounds (MPACs) for the Treatment of Alzheimer's Disease
pp. 75-82(8)
Authors: Barnham K.J.; Cherny R.A.; Cappai R.; Melov S.; Masters C.L.; Bush A.I.

The HIV Life Cycle: Multiple Targets for Antiretroviral Agents
pp. 83-92(10)
Authors: Alfano M.; Poli G.

Haemozoin Formation as a Target for the Rational Design of New Antimalarials
pp. 93-110(18)
Author: Egan T.J.